Add These 3 Stocks Under $10 Rated ‘Strong Buy’ to Your 2022 Watchlist

NYSE: MN | Manning & Napier, Inc.  News, Ratings, and Charts

MN – With the COVID-19 omicron variant proving so far to be less severe than previous coronavirus variants, and with the economic recovery continuing unabated, we think it’s time to add quality names Manning & Napier (MN), LifeVantage (LFVN), and Lifeway Foods (LWAY) to one’s watchlist for 2022. These stocks are currently trading at less than $10 per share but have a ‘Strong Buy’ rating in our proprietary rating system. So, let’s discuss.

The stock market was highly volatile last month, with fears surrounding the transmissibility of the COVID-19 omicron variant. However, the latest reports suggest that the omicron variant is less severe than the Delta variant. Preliminary reports also indicate that the risk of hospitalization is less if someone gets infected with the omicron variant.

The major market indexes scaled record highs last year. The economic recovery is expected to remain strong, and companies are expected to continue reporting stellar numbers this year. According to a FactSet report, the S&P 500 is expected to generate 9% year-over-year earnings growth in 2022, which surpasses the 10-year average earnings growth of 5%.

Given this backdrop, we think it could be wise to add quality low-priced stocks Manning & Napier, Inc. (MN), LifeVantage Corporation (LFVN), and Lifeway Foods, Inc. (LWAY) to one’s portfolio. These stocks have an overall ‘Strong Buy’ rating in our proprietary POWR Ratings system.

Manning & Napier, Inc. (MN)

MN in Fairport, N.Y., is an independent investment management firm that provides clients with a range of financial solutions and investment strategies. The company’s investment strategies are powered by multiple research engines, employing fundamental and quantitative approaches, and are offered as single and multi-asset class portfolios.

MN’s revenue for its fiscal third quarter, ended Sept. 30, 2021, increased 17% year-over-year to $37.50 million. The company’s average AUM increased 16% year-over-year to $22.40 billion. Its non-GAAP economic income came in at $6.87 million, representing a 115.6% increase year-over-year, and its non-GAAP economic EPS increased 114.2% year-over-year to $0.30.

Analysts expect MN’s EPS for its fiscal 2021 to increase 242.2% year-over-year to $0.42. The stock has gained 29.4% in price over the past year to close yesterday’s trading session at $8.11.

MN’s strong fundamentals are reflected in its POWR Ratings. It has an overall A rating, which equates to a Strong Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.

It has a B grade for Growth, Value, Momentum, Sentiment, and Quality. It is ranked #1 of 25 stocks in the B-rated Investment Brokerage industry. Click here to see MN’s rating for Stability also.

LifeVantage Corporation (LFVN)

LFVN in  Sandy, Utah, is engaged in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. Its products include Protandim, LifeVantage Omega+, TrueScience, and PhysIQ.

On November 17, 2021, LFVN announced that it had commenced business in the Philippines through its subsidiary Protandim Philippines Corporation. LFVN has expanded its operations across 20 countries with this foray into the Philippines.

For its fiscal first quarter, ended September 30, 2021, LFVN’s operating income increased 31.4% year-over-year to $4.60 million. The company’s operating expenses decreased 7.3% year-over-year to $15.10 million. In addition, its EPS came in at $0.25, up 47% year-over-year.

For its fiscal 2023, LFVN’s EPS and revenue are expected to increase 9.2% and 5%, respectively, year-over-year to $0.95 and $235.88 million. It surpassed the Street’s EPS estimates in three of the trailing four quarters. The stock has gained 3.9% in price over the past month to close yesterday’s trading session at $6.68.

LFVN’s POWR Ratings reflect this promising outlook. The stock has an overall A rating, which equates to a Strong Buy in our proprietary rating system. It has an A grade for Value and Quality and a B grade for Growth and Sentiment. LFVN is rated #2 of 12 stocks within the B-rated Medical – Consumer Goods industry. To see the other ratings of LFVN for Momentum and Stability, click here.

Lifeway Foods, Inc. (LWAY)

LWAY makes probiotic products, and its main products are the drinkable Kefir and the BioKefir. The Morton Grove, Ill.-based concern also makes European-style soft cheeses, farmer cheese, white cheese, and Sweet Kiss. In addition, it operates two retail stores and a food truck under its Lifeway Kefir shop subsidiary in the Chicago, Illinois, metropolitan area.

On August 18, 2021, LWAY announced that it had completed the acquisition of GlenOaks Farms, Inc. in an all-cash deal worth $5.80 million. This will likely help LWAY diversify its portfolio by entering the probiotic drinkable yogurt market.

For its fiscal third quarter, ended Sept. 30, 2021, LWAY’s net sales increased 13.5% year-over-year to $29.60 million. For the nine months ended Sept. 30, 2021, the company’s gross profit increased 10.8% year-over-year to $22.71 million. Also, its net income for the nine months ended Sep. 30, 2021, increased 15.3% year-over-year to $3.40 million. The stock gained 5.4% in price on the first trading session of 2022 to close at $4.85.

It is no surprise that LWAY has an overall rating of A, which equates to a Strong Buy in our POWR Rating system. It has an A grade for Growth and a B grade for Value, Stability, Sentiment, and Quality. Again, it is ranked #4 of 49 stocks in the Food Makers industry. Click here to see LWAY’s rating for Momentum as well.


MN shares were unchanged in premarket trading Tuesday. Year-to-date, MN has declined -2.41%, versus a 0.91% rise in the benchmark S&P 500 index during the same period.


About the Author: Dipanjan Banchur


Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
MNGet RatingGet RatingGet Rating
LFVNGet RatingGet RatingGet Rating
LWAYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Is the Bear Market Here?

We are witnessing the nastiest stock market (SPY) correction since Covid first came on the scene. That has some pondering if the next bear market is upon us. 40 year veteran investor Steve Reitmeister gives his clear eyed view on the market outlook and trading plan in this timely commentary. Get the full story below...

:  |  News, Ratings, and Charts

Looking for Value in the Tech Sector? Check Out These 4 Stocks

Tech stocks stumbled in the first trading week of this year over investors’ concerns about the looming interest rate hikes. Although a rising interest-rate environment does not bode well for technology companies, experts believe high demand for tech solutions will more than offset the negatives. So, we think it could be wise to bet on undervalued tech stocks International Business Machines (IBM), HP (HPQ), NortonLifeLock (NLOK), and Cirrus Logic (CRUS). Read on for more details.

:  |  News, Ratings, and Charts

3 Reasons to LOVE Stocks Under $10

The stock market can be a brutal place. Far too often, today’s winners will turn into tomorrow’s losers. Just think of all the excitement generated by stocks like Peleton, Zoom, and Teladoc. These stocks soared higher in 2020 and the early parts of 2021 only to crumble in recent months, punishing those who were greedy and overstayed their welcome. But, the opposite is also true. Read on below to find out more...

:  |  News, Ratings, and Charts

SoFi vs. Affirm: Which Fintech Stock is a Better Buy?

Today I will analyze and compare SoFi Technologies, Inc. (SOFI) and Affirm Holdings, Inc. (AFRM) to determine which fintech stock is a better buy,

:  |  News, Ratings, and Charts

3 Reasons to LOVE Stocks Under $10

The stock market can be a brutal place. Far too often, today’s winners will turn into tomorrow’s losers. Just think of all the excitement generated by stocks like Peleton, Zoom, and Teladoc. These stocks soared higher in 2020 and the early parts of 2021 only to crumble in recent months, punishing those who were greedy and overstayed their welcome. But, the opposite is also true. Read on below to find out more...

Read More Stories

More Manning & Napier, Inc. (MN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MN News